Allergic rhinitis decisions — 2025

The Board granted service connection for irritable bowel syndrome (IBS) and denied increased ratings for migraine headaches, reactive airway disease, and allergic rhinitis. The issues of service connection for eczema, pseudofolliculitis barbae, a right knee disability, and an increased rating for other reaction to severe stress disorder were remanded.

The Board denied earlier effective dates for the award of service connection for hypertension and CAD, granted a 10 percent evaluation for hypertension, and remanded several other claims.

The Board denied the veteran's claims for increased ratings and service connection, except for granting service connection for a left knee scar as secondary to his total knee replacement.

The Board remands the claims for service connection for allergic rhinitis and COPD to develop evidence regarding exposure to burn barrels in Vietnam.

The Board remands the case to schedule a VA examination for an in-person evaluation of the Veteran's allergic rhinitis due to inadequate medical evidence and a need for further development.

The Board granted service connection for dyshidrotic eczema of the hands and denied service connection for chronic headaches, sleep apnea, irritable bowel syndrome, allergic rhinitis, chronic sinusitis, left hip strain with various limitations, left knee joint osteoarthritis, pain of lumbar spine, and other specified trauma-and stressor-related disorder.

The Veteran's allergic rhinitis was granted a maximum schedular 30 percent rating from November 4, 2021, due to the presence of polyps.

The Board denied service connection for chronic rhinitis, allergic or non-allergic and urinary incontinence (loss of bladder control) as there was insufficient evidence to establish a causal link between the claimed conditions and the Veteran's military service. The remaining claims were remanded for further development.

The Board denied the veteran's claims for service connection and a compensable rating, as there was no evidence of current disabilities or sufficient in-service incurrence to support these claims.

The Board denied service connection for chronic fatigue syndrome, chronic sinusitis, an increased rating for hypertension, a compensable evaluation for allergic rhinitis, and increased ratings for sleep apnea syndrome and seasonal dyshidrotic eczema.

The Board denied the Veteran's appeal for an initial compensable rating for allergic rhinitis, as there was no evidence of greater than 50 percent obstruction of nasal passages on both sides or complete obstruction on one side, which would warrant a compensable rating.

The Board granted effective dates of May 31, 2023, for the awards of a 10 percent disability rating for rhinitis and a 50 percent disability rating for migraines. The award of service connection for urinary incontinence was denied an earlier effective date.

The Board dismissed the appeals for service connection and increased ratings as untimely, with no valid appeal under docket number 250102-497204.

The Board denied service connection for deviated septum and dismissed the appeals for separate compensable rating for headaches, rating in excess of 10 percent for pansinusitis and frontal sinusitis, rating in excess of 10 percent for allergic rhinitis, and service connection for right ankle strain due to procedural issues.

The appeal for service connection for acquired psychological disorders was dismissed, while service connection was granted for allergic rhinitis and pain of the left shoulder, lumbar spine, and cervical and cervicothoracic regions. The claim for bilateral hearing loss was denied, as well as a higher rating for chronic sinusitis.

The appeal for a disability rating higher than 10 percent for service-connected allergic rhinitis is dismissed as moot.

The Board dismissed the claims for service connection and increased rating due to procedural defects in the appeals process.

The Board remands the claims for service connection for PTSD, allergic rhinitis, and a respiratory disorder to correct duty to assist errors that occurred prior to the April 2024 AOJ decision on appeal.

The Board restored the 10 percent rating for allergic rhinitis effective April 1, 2025, and dismissed the proposal to discontinue DEA.

The Board granted service connection for acute sinusitis under the Sergeant First Class Heath Robinson Honoring our Promise to Address Comprehensive Toxins Act of 2022, but denied an evaluation in excess of 10 percent for allergic rhinitis.